Meanwhile, the tumor inhibition in response to PHLDA1 knockdown could be restored by miR-526b-5p inhibition, strongly suggesting PHLDA1 as a downstream target of miR-526b-5p to promote osteosarcoma tumorigenesis. The gene discussed is PHLDA1; the disease is neoplasm.